Xi H. Wang

State Key Laboratory Of Oncology In South China, 651 Dongfengdong
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Prognostic value of pre-treatment serum CA19-9 and lymphocyte-to-monocyte ratio in HR+/HER2- breast cancer: a retrospective cohort study.

Prognostic value of pre-treatment serum CA19-9 and lymphocyte-to-monocyte ratio in HR+/HER2- breast cancer: a retrospective cohort study.

Journal: BMC cancer
Published: February 19, 2026

Correction: Cancer cell employs a microenvironmental neural signal trans-activating nucleus-mitochondria coordination to acquire stemness.

Correction: Cancer cell employs a microenvironmental neural signal trans-activating nucleus-mitochondria coordination to acquire stemness.

Journal: Signal transduction and targeted therapy
Published: September 02, 2025

PPM1G promotes chemoresistance in triple negative breast cancer by enhancing YAP signaling.

PPM1G promotes chemoresistance in triple negative breast cancer by enhancing YAP signaling.

Journal: Pharmacological research
Published: July 16, 2025

Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial.

Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial.

Journal: The Lancet. Oncology
Published: June 04, 2025

The Prediction Model for Triple-Negative Breast Cancer Prognosis and Immunotherapy Efficacy Based on Single-Cell Sequencing of CD8+ T cells.

The Prediction Model for Triple-Negative Breast Cancer Prognosis and Immunotherapy Efficacy Based on Single-Cell Sequencing of CD8+ T cells.

Journal: Journal of Cancer
Published: April 10, 2025

Pathological complete response and prognostic predictive factors of neoadjuvant chemoimmunotherapy in early stage triple-negative breast cancer.

Pathological complete response and prognostic predictive factors of neoadjuvant chemoimmunotherapy in early stage triple-negative breast cancer.

Journal: Frontiers in immunology
Published: February 03, 2025

Identification of circulating tumor cells marker genes as prognostic signature in triple-negative breast cancer.

Identification of circulating tumor cells marker genes as prognostic signature in triple-negative breast cancer.

Journal: Discover oncology
Published: January 08, 2025

Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial.

Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial.

Journal: Breast cancer (Dove Medical Press)
Published: November 30, 2023

SHC4 orchestrates β-catenin pathway-mediated metastasis in triple-negative breast cancer by promoting Src kinase autophosphorylation.

SHC4 orchestrates β-catenin pathway-mediated metastasis in triple-negative breast cancer by promoting Src kinase autophosphorylation.

Journal: Cancer letters
Published: September 07, 2023

Development of a nomogram for predicting survival of breast cancer patients with neoadjuvant chemotherapy: a dynamic analysis for systemic inflammation response index.

Development of a nomogram for predicting survival of breast cancer patients with neoadjuvant chemotherapy: a dynamic analysis for systemic inflammation response index.

Journal: Gland surgery
Published: May 29, 2023

Effects of the crown ether cavity on the performance of anion exchange membranes.

Effects of the crown ether cavity on the performance of anion exchange membranes.

Journal: Journal of colloid and interface science
Published: February 05, 2023

Model for predicting immunotherapy based on M2 macrophage infiltration in TNBC.

Model for predicting immunotherapy based on M2 macrophage infiltration in TNBC.

Journal: Frontiers in immunology
Published: January 26, 2023
Showing 1-12 of 41

Last Updated: 09/26/2026